PeerVoice Oncology & Haematology Video

Geoffrey Ku, MD - Here’s The Challenge! Overcoming Tumour Heterogeneity in Gastric/GEJ Cancers

Stephanie Snow, MD, FRCPC - First-Line Immunotherapy in Advanced Non-Small Cell Lung Cancer: Discussing a Game Plan

Nick Pavlakis, MBBS, PLD / Kohei Shitara, MD - The Evolution of Treatment for Advanced Gastric and Oesophageal Cancers: New Insights From Key Congresses

Julia Rotow, MD / Javier Cortés, MD - HER3-Targeted Therapies: How Might These Benefit Our Patients?

Laurie H. Sehn, MD, MPH - Clinical Update in the Treatment of Mantle Cell Lymphoma: The Evolving Evidence of BTK Inhibitors

Hira Mian, MD, MSc, FRCPC - Moving the Needle in Relapsed Multiple Myeloma: Expert Insights to Address Key Questions in Patient Care

John Storring, MD, CM, FRCPC - Current Therapeutic Strategies for Targeted Therapy Selection in De Novo Acute Myeloid Leukemia

Emmanuella Guenova, MD, PhD - ‘T’ing Up Management of Mycosis Fungoides and Sézary Syndrome: Evaluating Blood Involvement and Its Impact on Patient Care

Stefano Fanti, MD - Evolving Evidence of Radioligand Therapy in Metastatic Prostate Cancer: A 2023 Clinical Round-Up From Key Congresses

Kevin Harrington, PhD, FRCR, FRCP - When CPS is Between 1 and 19, How Would You Manage Recurrent/Metastatic SCCHN?

Jun-ichi Nishimura, MD, PhD / Austin Kulasekararaj, MD, FRCPath / Jeffrey Szer, MBBS, FRACP - Haemolysis in Paroxysmal Nocturnal Haemoglobinuria: Applying Assessment and Mitigation Strategies for Patients Receiving Complement Inhibitors

Thomas Powles, MBBS, MRCP, MD - Education, Collaboration and Communication: Aligning Patient and Clinical Priorities in Locally Advanced and Metastatic Urothelial Carcinoma

Vijay Ramaswamy, MD, PhD, FRCPC - Managing the Pediatric Patient With Plexiform Neurofibromas: The Case for Systemic Therapy

Alicia K. Morgans, MD, MPH - What Would You Do Next? Exploring Expert Perspectives on Clinical Cases and Compelling Questions in mHSPC and nmCRPC

Julie Stakiw, MD, FRCPC - Clinical Conundrums in CLL: When to Use Continuous Versus Fixed-Duration Treatment

Mary Frances McMullin, MD, FRCP, FRCPath - Managing Myelofibrosis: Can We Do More to Address Cytopenias, Reduce Transfusion Burden, and Improve Quality of Life?

Arndt Vogel, MD - Mobilising the Multidisciplinary Team: Collaborative Strategies to Improve Care in Early- to Intermediate-Stage HCC

John Papastergiou, BScPhm, PhDc - Human Papillomavirus Head and Neck Cancers: Improving Outcomes in Adults Through Vaccination

Silke Gillessen, MD - Optimal Treatment of mCRPC: What Is the Place of Radioligand Therapy?

Gerald Prager, MD - Don't Leave a Drug on the Table: Maximising Use and Benefits of Later-Line Treatments for Advanced Colorectal Cancer

Michael P. Chu, MD - Chimeric Antigen Receptor T Cells: A New Step in Improving Multiple Myeloma Management

Solange Peters, MD, PhD - Advancing Our Patient-Centered Approach to Care in ALK-Positive Metastatic Non-Small Cell Lung Cancer

Brandon M. Meyers, MSc, MD, FRCPC - Raising the Bar in Advanced Hepatocellular Carcinoma Care: Insights to Optimize First-Line Treatment

Tanios Bekaii-Saab, MD - Expert Perspectives on Treatment Sequencing in Advanced CRC: Keys to Reaching Later Lines of Therapy

Anna Tinker, BScH, MD, FRCPC - Getting on the Case of Advanced Endometrial Cancer: How Biomarkers May Inform Immunotherapy Treatment Decisions